AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

Carnegie Mellon University and the University of Pittsburgh offered rare looks Thursday into two cutting-edge research facilities during a showcase for the U.S. National Security Commission on ...

If confirmed by the US Senate, Jim O'Neill would be the first non-scientist or engineer to lead the agency, a big funder of ...

For most students, science is limited to the lab bench — pipetting solutions and taking precise measurements to check the ...

Experts highlight biotechnology's potential to drive sustainable growth and career opportunities in India's emerging ...

SHANDONG, SHANDONG, CHINA, January 28, 2026 /EINPresswire.com/ -- In the rapidly evolving world of pet care, where "pet ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...

The European Directory of Biotechnology Companies offers key market opportunities by providing access to 2,000 biotech companies and 5,000 executives. It assists in pinpointing decision-makers, ...

The consensus estimate for Q4 2025 revenue is $23.18 million, and the earnings are expected to come in at -$0.41 per share. The full year 2025's revenue is expected to be $19.22 million, and the ...